69056-25-3

Basic information

• Product Name: 2-ACETOXY-3-PHENYL-PROPIONIC ACID
• Synonyms: 2-ACETOXY-3-PHENYL-PROPIONIC ACID;2-Acetoxy-3-phenylpropanoic acid
• CAS NO: 69056-25-3
• Molecular Formula: C₁₁H₁₂O₄
• Molecular Weight: 208.21058
• Mol File: 69056-25-3.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 350.351°C at 760 mmHg
• Flash Point: 136.147°C
• Appearance: /
• Density: 1.223g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.535
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-ACETOXY-3-PHENYL-PROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-ACETOXY-3-PHENYL-PROPIONIC ACID(69056-25-3)
• EPA Substance Registry System: 2-ACETOXY-3-PHENYL-PROPIONIC ACID(69056-25-3)

Safety Data

• Hazardous Substances Data: 69056-25-3(Hazardous Substances Data)

Usage

Also Known As

Phenylacetylsalicylic acid

Chemical Class

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Properties

Analgesic: Relieves pain.
Anti-inflammatory: Reduces inflammation.
Antipyretic: Reduces fever.

Mechanism of Action

Inhibits the production of prostaglandins, which are responsible for pain and inflammation.

Therapeutic Uses

Treatment of pain
Treatment of fever
Treatment of inflammation

Adverse Effects

Gastrointestinal bleeding
Kidney damage

Caution

Prolonged use or high doses may lead to adverse effects.

Recommendation

Use under the guidance of a healthcare professional.

InChI:InChI=1/C11H12O4/c1-8(12)15-10(11(13)14)7-9-5-3-2-4-6-9/h2-6,10H,7H2,1H3,(H,13,14)

Upstream product

• 75-36-5 acetyl chloride 
• 828-01-3 phenyllactic acid 
• 108-24-7 acetic anhydride 
• 150-30-1 Phenylalanine 
• 127-09-3 sodium acetate 
• 108-05-4 vinyl acetate 

Downstream Products

• 13674-16-3 methyl 2-hydroxy-3-phenylpropanoate 
• 95393-19-4 2-acetoxy-3-phenylpropanoyl chloride 
• 92702-58-4 α-Acetoxy-β-phenyl-propionsaeure-N,N-diaethylamid 
• 20312-36-1 L-3-phenyllactic acid 
• 146235-25-8 (2R)-2-acetoxy-3-phenylpropanoic acid 
• 868532-36-9 acetic acid 1-benzyl-2-oxo-2-(2-thioxo-oxazolidin-3-yl)-ethyl ester 
• 828-01-3 D-phenyllactic acid 
• 33173-31-8 (S)-3-phenyl-2-acetyloxypropionic acid 
• 18859-19-3 N,N-diethyl-3-phenylpropanamide 
• 151647-54-0 3-phenyl-1-pyrrolidin-1-yl-propane-1-one 
• 110271-88-0 (E)-2-(1-Methoxycarbonyl-2-phenyl-ethoxy)-3-phenyl-acrylic acid methyl ester 
• 110271-83-5 C₁₈H₂₄N₂O₆ 
• 110271-79-9 4-Benzyl-5-methoxy-[1,2,3]oxadiazole-2,3-dicarboxylic acid diisopropyl ester 
• 1027336-35-1 C₁₆H₁₈O₇ 

Relevant articles and documents

CHROMENOPYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS

The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula (I); where A1, A2, G, R1, R2, R3, R4, and W are described herein.

Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): Tetramic, tetronic acids and dihydropyridin-2-ones

Based on a pharmacophore hypothesis substituted tetramic and tetronic acid 3-carboxamides as well as dihydropyridin-2-one-3-carboxamides were investigated as inhibitors of undecaprenyl pyrophosphate synthase (UPPS) for use as novel antimicrobial agents. S

Enantio-complementary deracemization of (±)-2-hydroxy-4- phenylbutanoic acid and (±)-3-phenyllactic acid using lipase-catalyzed kinetic resolution combined with biocatalytic racemization

Deracemization of (±)-3-phenyllactic acid (1) and (±)-2-hydroxy-4-phenylbutanoic acid (2) was accomplished by lipase-catalysed kinetic resolution coupled to biocatalytic racemization of the non-reacting substrate enantiomers using Lactobacillus paracasei DSM 20008. Cyclic repetition of this sequence led to a single enantiomeric product from the racemate. Access to both enantiomers was achieved by switching between lipase-catalysed acyl-transfer and ester hydrolysis reactions. Both products constitute important building blocks for virus protease- and ACE-inhibitors, respectively.